Concepedia
Statistics
Publications
122
Citations
15.6K
H-Index
65
Active since
1994
Affiliations
Novartis (United States)(Current)
Novartis (China)
Novartis (Switzerland)
Moffitt Cancer Center
University of South Florida
Peter Atadja is an author at Novartis (United States) specializing in medicine, cell biology, and tumor biology.
Top concepts
MedicineCell BiologyTumor BiologyCancer ResearchPharmacologyOncologyRadiation OncologyChromatinEpigeneticsNatural Sciences
Publications per year
1994–2023
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
Hui Gao, Joshua M. Korn, Stéphane Ferretti et al. · Nature Medicine · 2015 · 1.4K citations
Tumor Biology, Radiology, Oncology +10
Inhibition of Histone Deacetylase 6 Acetylates and Disrupts the Chaperone Function of Heat Shock Protein 90
Purva Bali, Michael Pranpat, James E. Bradner et al. · Journal of Biological Chemistry · 2005 · 746 citations · Full text
Cloning and Functional Characterization of HDAC11, a Novel Member of the Human Histone Deacetylase Family
Lin Gao, Maria A. Cueto, Peter Atadja · Journal of Biological Chemistry · 2002 · 718 citations · Full text
Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation
Wei Qi, Homan Chan, Lin Teng et al. · Proceedings of the National Academy of Sciences · 2012 · 542 citations · Full text
Selective Inhibition, Tumor Biology, Methyl Group +15
The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance
Alejandro Villagra, Fengdong Cheng, Hongwei Wang et al. · Nature Immunology · 2008 · 447 citations
Chromatin, Immune Tolerance, Chromatin Structure +14
1–5 of 122